Author

K. A. Egland

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Immunology· 1 Microbiology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:drug response / drug discovery· 2 Approach:experimental assay· 2 Research Focus:host-pathogen & immune response· 1 Organism:human· 1

Frequent Co-Authors

C. L. Bausch· 2 shared E. J. Sullivan· 2 shared H. Wu· 2 shared M. D. Dunn· 1 shared S. P. J. Whelan· 1 shared T. C. Gilliland· 1 shared T. C. Luke· 1 shared T. Luke· 1 shared

Activity by Year

2021-2021 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 39 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersImmunology

C. L. Bausch

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

ImmunologybioRxivPreprintAug 9, 2021

Fully Human Antibody Immunoglobulin from Transchromosomic Bovines is Potent Against SARS-CoV-2 Variant Pseudoviruses

T. Luke, H. Wu, K. A. Egland…·C. L. Bausch

This study evaluates the neutralization potency of SAB-185, a fully human antibody immunoglobulin from transchromosomic bovines, against multiple SARS-CoV-2 variants using pseudovirus assays.

DOI 10.1101/2021.08.09.454215

humanexperimental assay

𝕏 PostBluesky

MicrobiologybioRxivFeb 6, 2021

Human immunoglobulin from transchromosomic bovines hyperimmunized with SARS-CoV-2 spike antigen efficiently neutralizes viral variants.

Z. Liu, H. Wu, K. A. Egland…·S. P. J. Whelan

This paper describes a fully human immunoglobulin from transchromosomic bovines that neutralizes SARS-CoV-2 variants, including those with mutations like E484K and N501Y.

DOI 10.1080/21645515.2021.1940652

experimental assayhost-pathogen & immune response

𝕏 PostBluesky